These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 13456038)

  • 1. Terminal carcinoma of the breast; palliative therapy with depo-testosterone.
    PETERSON CG
    U S Armed Forces Med J; 1957 Aug; 8(8):1152-9. PubMed ID: 13456038
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of enolic derivatives of testosterone, in combination with radiotherapy, in patients with metastasizing neoplasms of the breast and of the genital area].
    SIGHINOLFI R
    Policlinico Prat; 1962 Apr; 69():532-40. PubMed ID: 14039271
    [No Abstract]   [Full Text] [Related]  

  • 3. Nandrolone phenpropionate: a new palliative agent in the management of mammary carcinoma.
    SZUJEWSKI HA
    Am Pract Dig Treat; 1959 Dec; 10():2157-9. PubMed ID: 13836459
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of 2 alpha-methyl androstan-17 beta-ol, 3-one (2-methyl dihydrotestosterone) in the treatment of advanced cancer of the breast.
    BLACKBURN CM; CHILDS DS
    Proc Staff Meet Mayo Clin; 1959 Mar; 34(5):113-26. PubMed ID: 13658242
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormonal therapy of metastatic female breast carcinoma. II. 2alpha-Methyl dihydrotestosterone propionate.
    GOLDENBERG IS; HAYES MA
    Cancer; 1961; 14():705-6. PubMed ID: 13706491
    [No Abstract]   [Full Text] [Related]  

  • 6. The hormone treatment of advanced breast cancer: comparative therapy with testosterone and two experimental androgens.
    LEWISON EF; GROW JL; TRIMBLE FH
    Am Surg; 1960 Apr; 26():278-83. PubMed ID: 14416562
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary results with the use of non-androgenic derivatives of testosterone in the treatment of advanced breast cancer. Preliminary note].
    MAINOLDI F; MONETTI C; GALLETTI F
    Radiobiol Radioter Fis Med; 1961 May; 16():99-109. PubMed ID: 13765471
    [No Abstract]   [Full Text] [Related]  

  • 8. [The n-octylenolic ether of dihydrotestosterone associated with x-ray therapy in the treatment of advanced breast carcinoma].
    MAINOLDI F; MONETTI C
    Radiobiol Radioter Fis Med; 1961 Dec; 16():415-26. PubMed ID: 14468532
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences in the treatment of metastases from breast carcinoma with an enolic derivative of dihydrotestosterone].
    CHELI C
    Minerva Med; 1962 May; 53():1591-5. PubMed ID: 13878587
    [No Abstract]   [Full Text] [Related]  

  • 10. [The hormonal treatment of metastases of cancer of the breast].
    MASSE L
    J Med Bord; 1962 Apr; 139():489-91. PubMed ID: 14470904
    [No Abstract]   [Full Text] [Related]  

  • 11. 54-year-old man with breast cancer after prolonged testosterone therapy.
    Sorscher S; Krause W
    Clin Adv Hematol Oncol; 2005 Jun; 3(6):475; discussion 476. PubMed ID: 16167025
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of 2alpha-methyldihydrotestosterone propionate in treatment of advanced cancer of the breast: a group report.
    BLACKBURN CM
    Cancer Chemother Rep; 1962 Feb; 16():279-82. PubMed ID: 13869675
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormonal alteration of malignant tumors in the clinic].
    MARTZ G
    Strahlentherapie; 1961; Suppl 48():175-81. PubMed ID: 14470641
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor efficacy of 2alpha-methyl dihydrotestosterone propionate in advanced breast cancer.
    THOMAS AN; GORDAN GS; GOLDMANL ; LOWE R
    Cancer; 1962; 15():176-8. PubMed ID: 13920749
    [No Abstract]   [Full Text] [Related]  

  • 15. [Durabolin in bone pathology].
    DREYFUS P
    Gaz Med Fr; 1961 Nov; 68():2579-81. PubMed ID: 13887846
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormonal therapy in cancer of the breast. XV. Effect of epitestosterone propionate on clinical course and hormonal excretion.
    SEGALOFF A; BOWERS CY; RONGONE EL; MURISON PJ
    Cancer; 1959; 12():1270-2. PubMed ID: 14444544
    [No Abstract]   [Full Text] [Related]  

  • 17. Paradoxical response of metastatic breast cancer to 17-ethyl-19-nortestosterone.
    EMERSON K; MULLER J; de SOUZA ; LOUTFI G
    Ann Intern Med; 1961 Nov; 55():742-8. PubMed ID: 13890104
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical effect of norandrostenolone phenylpropionate (durabolin) in metastasizing mammary cancer patients.
    MALMIO K; HISI-BRUMMER L; HORTLING H
    Ann Med Intern Fenn; 1960; 49():121-29. PubMed ID: 14420398
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peculiarities of steroid metabolism in mastopathy and breast cancer under the effect of testosterone].
    SCHUBERT K; BACIGALUPO G
    Arch Geschwulstforsch; 1960; 16():222-37. PubMed ID: 13748718
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of a breast cancer patient with Endoxan and an anabolic hormone. Empirical report].
    KILL JM
    Munch Med Wochenschr; 1961 Sep; 103():1767-8. PubMed ID: 13755948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.